Secondaries announced 10.22.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Vital Therapies
Symbol: VTL
Price: Last trade $5.51
Trade Date: 10/23
Shares: 5.4 million
Underwriter(s) BofA Merrill Lynch
Rating=Subscription Needed